113
Here we sought to investigate the mechanical mechanisms of pulmonary vascular and RV dysfunction in a 114 rodent model of PH-LHF. We further compare our pathophysiological findings to published data from PH-LHF 115 patients to verify the ability of our rodent model to recapitulate critical aspects of the human disease. 
129
Experiments were conducted in an unbiased approached with adherence to the recently published PH pre-clinical 130 research guidelines (4, 62) . Power calculations were completed to determine appropriate group sizes; animals were 131 randomized to either MI or sham groups; experimental conditions were standardized to every degree possible, 132 meaning end points of comprehensive hemodynamics (as descried below) were used; and analysis was blinded when 133 possible (i.e., for histological analysis and isolated lung perfusion analysis).
135

Echocardiography
136
Transthoracic echocardiography (TTE) was conducted to assess left ventricular morphology and function in 137 vivo. As previously described, mice were anesthetized with 5% isoflurane and then maintained with 1-2% isoflurane 138 and room air throughout the procedure; body temperature was maintained at 37°C using a heated platform (16, 21) .
139
Echocardiographic parameters were measured over at least three consecutive cardiac cycles and averaged.
141
In vivo right ventricular and pulmonary vascular hemodynamics
142
Surgical preparation, hemodynamic measurements, and analysis were based on established protocols (20, 143 21, 65, 70) . Anesthesia was induced with an intraperitoneal injection of urethane solution (1 mg/g body weight) to 144 maintain heart rate. Mice were then intubated and placed on a ventilator (Harvard Apparatus, Holliston, MA). As 145 previously described, the thoracic cavity was entered, and the heart was exposed by removal of anterior rib cage (21, 65, 70) . This open chest technique was used because the stiffness of the catheter used for right ventricular (RV) 147 pressure and volume measurements precludes a closed chest approach with catheter insertion through the jugular 148 vein. Left ventricular (LV) pressure was measured with a pressure catheter (Millar, Houston, TX) inserted from the 149 common carotid artery and advanced through the aortic valve into the LV. Heart rate and systemic pressure were 150 recorded and observed throughout the procedure. RV pressure-volume loops were obtained as previously described 151 using a 1.2 F admittance catheter inserted through the apex of the heart into the RV. After instrumentation was 152 established and baseline pressure-volume measurements were obtained, the inferior vena cava (IVC) was isolated 153 and briefly occluded to obtain alterations in venous return for determination of end-systolic and end-diastolic 154 pressure relations. One MI mouse expired shortly following placement of the catheter into the RV such that only 155 pressure measurements could be obtained. A second MI mouse expired during IVC occlusions and only baseline 156 pressure-volume loops were obtained for that animal. Commercial software (Notocord, Croissy Sur Seine, France) 157 recorded RV pressure and volume waveforms simultaneously, and data were analyzed using a minimum of 10 158 consecutive cardiac cycles. Cardiac output (CO) was normalized by body weight (BW) to calculate the cardiac index
159
(CI) (20, 21, 36, 65, 70) .
160
Pulmonary vascular mechanical function quantified using total pulmonary vascular resistance (TPVR), 161 pulmonary vascular resistance (PVR), and transpulmonary gradient (TPG). TPVR was calculated as mean 162 pulmonary artery pressure (mPAP) divided by CO, where mPAP was assumed to be equal to right ventricular end 163 systolic pressure (RVSP) (7, 65). PVR was determined as (mPAP-mLAP/CO) where mLAP was assumed equal to
164
LV end diastolic pressure (LVEDP) (5). TPG was computed as mPAP-mLAP
165
RV mechanical function was assessed using established parameters including maximum and minimum 166 pressure derivatives (dP/dt max , dP/dt min ), end systolic elastance (E es ), and the slope of dP/dt max -end diastolic volume 167 (V ed ) relationship obtained from inferior vena cava occlusions (21, 57, 70) . Ventricular-vascular interactions were 168 assessed using E es /E a (21, 70). Finally, cardiac energetics were assessed via pressure-volume area (PVA), external 169 mechanical work (EW), and ventricular mechanical efficiency (EW/PVA) as previously reported (45, 55) .
171
Ex vivo pulmonary vascular pressure-flow dynamics
172
The isolated, ventilated, perfused lung preparation was used as previously validated and detailed by our 173 group (73, 76) . Briefly, following euthanasia with 150mg/kg of pentobarbital, the trachea was cannulated for 174 ventilation. The lungs were ventilated with room air between end expiratory and end inspiratory pressures of 175 ~1mmHg and ~8mmHg, respectively. Following cannulation of the trachea, 1mL of heparin (1.25mg/mL) was 176 injected into the right ventricle to prevent clots from forming in the pulmonary vasculature (76). Subsequently, the 177 pulmonary artery and left atrium were cannulated for perfusate inflow and outflow, respectively (76, 77). The lungs 178 were perfused with warm RPMI 1640 cell culture medium with 3.5% Ficoll (an oncotic agent). Steady state 179 perfusion was conducted using a syringe pump and pulsatile flow was achieved using a high-frequency oscillatory 
187
The pulsatile flow measurements were performed and recorded as previously validated (73, 76) . The lungs 188 were initially perfused with RPMI at 1mL/min for 2 min or until lungs were fully perfused and had turned white.
189
The flow rate was then increased to 3mL/min and sinusoidal flow rates of the form Q = 3 + 2 sin (2πft) mL/min 190 were generated for frequencies of f = 1, 2, 5, 10, 15, and 20 Hz. This range of frequencies was chosen to fully 191 include the physiologic heart rate of mice (~10Hz) (73). The lungs were held at end expiratory pressure (~1mmHg) 192 throughout data collection, and PAP, LAP, and Q were recorded as described above. Immediately following the 193 pulsatile flow protocol, the lungs were allowed to rest at a flow rate of 0.5mL/min for 1 min and normal ventilation 194 was resumed, along with intermittent deep inspirations of ~15 mmHg to maintain airway patency.
195
After the pulsatile flow protocol and rest period, steady state measurements were obtained. First, the flow 196 rate was increased to 1mL/min and then flow rate was increased to 5mL/min in increments of 1mL/min with PAP,
197
LAP, and Q recorded once steady state was reached. The flow rate was then decreased from 5 to 1mL/min, again at 
208
Tissue harvest, fixation, and histology
209
Following either completion of the isolated lung procedure or right heart catheterization, the heart and 210 lungs were removed from the mouse. The RV was then separated from the LV and septum, and the LA and RA were 211 also separated. Heart tissues were weighed and then divided for preservation by either flash freezing or placement in
212
10% formalin. The right and left lungs were separated and weighed. The right lung was preserved in 10% formalin 213 and the left lung was flash frozen.
214
Harvested tissues following right heart catheterization that were fixed in 10% formalin as described above
215
were preserved in 70% ethanol. Tissues were then embedded in paraffin, sectioned, and stained as detailed below for 216 histological analysis.
218
Perivascular Pulmonary fibrosis
Pulmonary sections were stained with picrosirius red to assess collagen deposition, as previously described (21, 79).
220
An inverted microscope (TE-2000-5; Nikon, Melville, NY) was used to acquire histological images using a Spot
221
CCD camera (Optical Analysis Systems, Nashua, NH). The area of perivascular collagen was determined using 222 color thresholding in a representative field of view by an observer blinded to the experimental groups using
223
MetaVue software (Optical Analysis Systems). In the RV, collagen area was divided by total tissue area of the 224 representative image to calculate collagen area percent (21, 79). In pulmonary arterioles, collagen area was divided
225
by the perimeter of the identified arteriole. Pulmonary arterioles were differentiated from venules by their immediate 226 proximity to airways (72). Arteriole diameters ranged from 50-200µm.
227
Pulmonary vascular remodeling 228
Verhoeff-Van Giesson immunohistochemical staining was performed on paraffin-embedded lung sections 229 as previously described (22). In a blinded fashion, pulmonary arteries <200 µm in diameter were identified by 230 proximity to terminal bronchioles or alveolar ducts under a 20X objective as previously described (41 and LV weight, which includes LV + septum (S), were elevated, demonstrating left sided cardiac remodeling (Table   275 1) which is consistent with the LV dilation determined by echocardiography ( Figure 1A&B ). Additionally, there was 276 a significant increase in the absolute RV weight as well as the RV weight indexed to body weight. Interestingly, the
277
Fulton index (RV weight indexed to the weight of LV + S) was unchanged, indicating RV hypertrophy occurred in
278
proportion to LV remodeling (Table 1) . Analysis of lung tissues demonstrated a trend towards increased wet lung 279 weight which did not reach statistical significance.
281
Development of secondary PH and right ventricular dysfunction post-MI
282
Invasive hemodynamic measurements were obtained at 12 weeks post-MI. LV end diastolic pressure 283 (LVEDP) increased over 4-fold following MI (Table 2 ). In addition, there was a significant increase in RV systolic 284 pressure (RVSP) ( Table 2) , demonstrating the development of secondary pulmonary hypertension. Consistent with this, there was a doubling of the total pulmonary vascular resistance (TPVR) and a significant increase in the 286 transpulmonary pressure gradient (TPG) in the post-MI group. There was also a significant elevation in RV afterload 287 as measured by the arterial elastance (E a ) (Figure 2A) .. Hemodynamic analysis further demonstrated significantly 288 lower cardiac output (CO) post-MI (Table 2) , which is consistent with the development of HFrEF ( Figure 1C ).
289
In the setting of reduced CO, RV systolic function was largely preserved as demonstrated by maintained
290
RVEF and stroke work (SW) ( Table 2 ). Despite maintained function by some indices, pressure-volume loops 291 obtained with varying preload (Figure 2A ) demonstrate a significant decrease in end systolic elastance (E es ) ( Figure   292 2A&C). In combination with the increased RV afterload (E a ), decreased E es resulted in RV-pulmonary vascular 293 uncoupling (Figure 2 ). In the setting of pulmonary arterial hypertension, ventricular-vascular uncoupling suggests 294 development of RV dysfunction (RVD) and is predictive of increased mortality (1, 6, 32, 38, 58) . In addition,
295
increased τ and decreased chamber compliance provide evidence of RV diastolic dysfunction (Table 2 ). There was a 296 trend towards decreased RV volumes as measured by right heart catheterization ( Table 2 ). These findings were
297
consistent with echocardiographic assessments that demonstrated no change in RV internal diameter (data not 298 shown).
299
We further evaluated RV mechanical energy consumption and output. There was a significant increase in
300
RV energy consumption, as measured by pressure volume area (PVA) (Figure 3 ). However, despite this increase in 301 consumption, RV mechanical energy output as measured by external work (EW) was similar to sham ( Figure 3 ).
302
Taken together, this resulted in a significant decrease in mechanical efficiency (EW/PVA) occurring in the setting of 303 post-MI secondary PH (Figure 3 ).
305
Increased PVR and Impedance post-MI
306
In vivo hemodynamic analysis demonstrated increased afterload measured by E a ( Figure 2B ) in addition to 307 increased TPVR and LVEDP (Table 2) Table 3 ). There was a trend towards increased Z c , a measure 315 of proximal arterial elastance, which did not reach statistical significance and no change in wave reflection index,
316
R w , an indicator of pulse pressure wave reflections (Table 3 ). Similar to the findings for Z c , there was a trend toward 317 reduced distensibility, α, which was not statistically significant (Table 3) . and TPVR ( Figure 5C&D ). These findings demonstrate that perivascular remodeling characterized by increased 326 collagen deposition is one mechanism contributing to the development of increased PVR in secondary PH.
327
Pulmonary arterial remodeling was further assessed by examination of medial hypertrophy using Verhoeff-van
328
Giesson staining and calculation of PA wall area fraction (Figure 5 E) . Analysis demonstrated no evidence of medial 329 hypertrophy in the post-MI group, which actually showed a slight decrease in PA wall area fraction compared to 330 control. In order to assess for pulmonary artery cell proliferation, proliferating cell nuclear antigen (PCNA) 331 expression was measured in lung homogenates from sham or MI animals. As demonstrated in Figure 5F there was 332 no difference in PCNA between the Sham and MI groups.
334
Discussion:
335
This study investigated the mechanical mechanisms of pulmonary vascular and RV dysfunction due to 336 secondary PH in a mouse model of ischemic heart failure with reduced ejection fraction (HFrEF). We observed the 337 following changes in the pulmonary vasculature: increased PVR, Z 0 , and E a . These were associated with 338 perivascular fibrosis in the pulmonary arteries. RV diastolic dysfunction occurred in addition to reduced E es and 339 ventricular-vascular uncoupling. While cardiac output decreased in the setting of MI leading to HRrEF, RV ejection 340 fraction was preserved, indicating that RV failure had not yet developed.
341
Our findings of increased LVEDP, RVSP, and RVH are consistent with previous studies showing evidence
342
of PH-LHF in rodent models (2, 8, 31, 33, 37, 49, 56, 61, 80) . In addition to documenting the development of PH in 
375
RV diastolic dysfunction did not correlate with degree of PH and occurred in patients with LHF without PH (81).
376
There was no RV dilation found in our PH-LHF model, which is consistent with a state of RV dysfunction rather 377 than failure as RV dilation has been shown to occur late in the progression to RV failure (3, 78).
378
While this study provides important insights into PH-LHF, there are important limitations to note. Invasive 379 measurements of pulmonary vascular and right ventricular function were completed at a single time point.
380
Therefore, causal relationships between right ventricular and pulmonary vascular hemodynamic changes or between 381 structural and functional changes cannot be determined. We document RV hypertrophy but did not elucidate when it 
387
Additionally, further evaluation of pulmonary vascular remodeling including pulmonary artery calcification, 388 pulmonary capillary remodeling and pulmonary venous remodeling are important areas to be addressed in future 389 work. It is important to note that diastolic pressure gradient, the primary metric for distinguishing Ipc-PH and Cpc-
390
PH in clinical practice, was not able to be determined as pulmonary artery pressures were not directly measured in 391 vivo. Both PVR and TPG, two key features of Cpc-PH (28, 50), were assessed both in vivo and ex vivo. In All data expressed as mean ± standard error
